期刊
PLOS ONE
卷 6, 期 8, 页码 -出版社
PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0024445
关键词
-
资金
- Mukoviszidose e.V.
- Deutsche Forschungsgemeinschaft (DFG) [MA 2081/4-1]
- FCT - Fundacao para a Ciencia e a Tecnologia, Portugal [PIC/IC/83103/2007]
- FEDER - Fundo Europeu de Desenvolvimento Regional, EU
- Fundação para a Ciência e a Tecnologia [PIC/IC/83103/2007] Funding Source: FCT
Background: The identification of strategies to improve mutant CFTR function remains a key priority in the development of new treatments for cystic fibrosis (CF). Previous studies demonstrated that the K+ channel opener 1-ethyl-2-benzimidazolone (1-EBIO) potentiates CFTR-mediated Cl- secretion in cultured cells and mouse colon. However, the effects of 1-EBIO on wild-type and mutant CFTR function in native human colonic tissues remain unknown. Methods: We studied the effects of 1-EBIO on CFTR-mediated Cl- secretion in rectal biopsies from 47 CF patients carrying a wide spectrum of CFTR mutations and 57 age-matched controls. Rectal tissues were mounted in perfused micro-Ussing chambers and the effects of 1-EBIO were compared in control tissues, CF tissues expressing residual CFTR function and CF tissues with no detectable Cl- secretion. Results: Studies in control tissues demonstrate that 1-EBIO activated CFTR-mediated Cl- secretion in the absence of cAMP-mediated stimulation and potentiated cAMP-induced Cl- secretion by 39.266.7% (P, 0.001) via activation of basolateral Ca2+-activated and clotrimazole-sensitive KCNN4 K+ channels. In CF specimens, 1-EBIO potentiated cAMP-induced Cl- secretion in tissues with residual CFTR function by 44.4611.5% (P, 0.001), but had no effect on tissues lacking CFTR-mediated Cl- conductance. Conclusions: We conclude that 1-EBIO potentiates Cl- secretion in native CF tissues expressing CFTR mutants with residual Cl- channel function by activation of basolateral KCNN4 K+ channels that increase the driving force for luminal Cl- exit. This mechanism may augment effects of CFTR correctors and potentiators that increase the number and/or activity of mutant CFTR channels at the cell surface and suggests KCNN4 as a therapeutic target for CF.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据